title: Influence of pH on extracellular matrix preservation during lung decellularization.
abstract: The creation of decellularized organs for use in regenerative medicine requires the preservation of the organ extracellular matrix (ECM) as a means to provide critical cues for differentiation and migration of cells that are seeded onto the organ scaffold. The purpose of this study was to assess the influence of varying pH levels on the preservation of key ECM components during the decellularization of rat lungs. Herein, we show that the pH of the 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)-based decellularization solution influences ECM retention, cell removal, and also the potential for host response upon implantation of acellular lung tissue. The preservation of ECM components, including elastin, fibronectin, and laminin, were better retained in the lower pH conditions that were tested (pH ranges tested: 8, 10, 12); glycosaminoglycans were preserved to a higher extent in the lower pH groups as well. The DNA content following decellularization of the rat lung was inversely correlated with the pH of the decellularization solution. Despite detectible levels of cyotoskeletal proteins and significant residual DNA, tissues decellularized at pH 8 demonstrated the greatest tissue architecture maintenance and the least induction of host response of all acellular conditions. These results highlight the effect of pH on the results obtained by organ decellularization and suggest that altering the pH of the solutions used for decellularization may influence the ability of cells to properly differentiate and home to appropriate locations within the scaffold, based on the preservation of key ECM components and implantation results.
authors.affiliation: 1 Department of Biomedical Engineering, Yale University , New Haven, Connecticut.
authors.forename: Tomoshi
authors.initials: T
authors.lastname: Tsuchiya
authors.forename: Jenna L
authors.initials: JL
authors.lastname: Balestrini
authors.forename: Julio
authors.initials: J
authors.lastname: Mendez
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Calle
authors.forename: Liping
authors.initials: L
authors.lastname: Zhao
authors.forename: Laura E
authors.initials: LE
authors.lastname: Niklason
mesh_terms: D000818:Animals; D002793:Cholic Acids / Q000494:pharmacology*; D003094:Collagen / Q000378:metabolism; D004549:Elastin / Q000378:metabolism; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism*; D005353:Fibronectins / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D020007:Implants, Experimental; D007797:Laminin / Q000378:metabolism; D008168:Lung / Q000166:cytology* / Q000187:drug effects / Q000648:ultrastructure; D008297:Male; D017207:Rats, Sprague-Dawley; D040521:Subcutaneous Tissue / Q000502:physiology; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D002793:Cholic Acids; D005353:Fibronectins; D006025:Glycosaminoglycans; D007797:Laminin; D003094:Collagen; D004549:Elastin; C028213:3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate
references.citation: Ann Thorac Surg. 2011 Sep;92(3):998-1005; discussion 1005-6
references.pmid: 21871290
references.citation: Tissue Eng Part A. 2010 Aug;16(8):2565-80
references.pmid: 20408765
references.citation: Tissue Eng Part C Methods. 2012 Jun;18(6):420-32
references.pmid: 22165818
references.citation: Biomaterials. 2005 Apr;26(11):1237-45
references.pmid: 15475053
references.citation: Acta Biomater. 2011 Mar;7(3):1241-8
references.pmid: 21094703
references.citation: Annu Rev Cell Dev Biol. 2004;20:255-84
references.pmid: 15473841
references.citation: J Appl Physiol (1985). 2000 Jul;89(1):3-14
references.pmid: 10904029
references.citation: Tissue Eng. 2003 Oct;9(5):871-9
references.pmid: 14633372
references.citation: J Clin Pathol. 1964 Nov;17:685-6
references.pmid: 14227441
references.citation: J Appl Physiol (1985). 2005 Feb;98(2):672-9
references.pmid: 15448123
references.citation: Science. 2010 Jul 30;329(5991):538-41
references.pmid: 20576850
references.citation: Transpl Immunol. 2004 Apr;12(3-4):367-77
references.pmid: 15157928
references.citation: Nat Med. 2010 Aug;16(8):927-33
references.pmid: 20628374
references.citation: Expert Opin Biol Ther. 2010 Dec;10(12):1717-28
references.pmid: 21058932
references.citation: Nat Med. 2008 Feb;14(2):213-21
references.pmid: 18193059
references.citation: J Biomed Mater Res A. 2014 Mar;102(3):698-712
references.pmid: 23723042
references.citation: J Cell Sci. 2002 Jul 15;115(Pt 14):2817-28
references.pmid: 12082143
references.citation: Nat Med. 2013 May;19(5):646-51
references.pmid: 23584091
references.citation: Am J Respir Cell Mol Biol. 2013 Nov;49(5):731-40
references.pmid: 23590307
references.citation: Exp Lung Res. 2003 Apr-May;29(3):135-47
references.pmid: 12637226
references.citation: Tissue Eng. 2006 Mar;12(3):519-26
references.pmid: 16579685
references.citation: Tissue Eng. 2007 Aug;13(8):1893-904
references.pmid: 17518731
references.citation: Biomaterials. 2006 Jul;27(19):3675-83
references.pmid: 16519932
references.citation: Lancet. 2008 Dec 13;372(9655):2023-30
references.pmid: 19022496
references.citation: Annu Rev Biomed Eng. 2011 Aug 15;13:27-53
references.pmid: 21417722
references.citation: Cells Tissues Organs. 2012;195(3):222-31
references.pmid: 21502745
references.citation: Am J Physiol. 1996 Jan;270(1 Pt 1):L3-27
references.pmid: 8772523
references.citation: Dev Biol. 2006 Jun 15;294(2):271-9
references.pmid: 16643883
references.citation: Biomaterials. 2000 Nov;21(22):2215-31
references.pmid: 11026628
references.citation: Ann Biomed Eng. 2014 Jul;42(7):1517-27
references.pmid: 24402648
references.citation: Tissue Eng Part C Methods. 2010 Apr;16(2):173-84
references.pmid: 19419244